PCN113 Cost-Utility Analysis of Combination Therapy of Pegylated Liposomal Doxorubicin(PLD) and Carboplatin for Korean Women with Platinum-Sensitive Ovarian Cancer
Abstract
Authors
H.Y. Lee J.M. Hong B.M. Yang T.J. Lee B.G. Kim S.B. Kang Y.T. Kim Y.M. Kim J.W. Kim J.M. Yang Y.J. Jung